ReviewAnnals of hematology2025

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review.

Daisuke Ogiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.